151.68
-6.32 (-4.0%)
-6.32 (-4.0%)
Upgrade to Real-Time
Regular Market
| Volume | 1,634,925 |
|
|||||
| News | - | ||||||
| Day High | 158.5099 | Low High |
|||||
| Day Low | 151.27 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -6.32 | -4.0% | 151.68 | 10:31:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 157.00 | 151.27 | 158.5099 | 158.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,632 | 1,634,925 | $ 154.30 | $ 252,271,200 | - | 115.61 - 464.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:31:10 | 3 | $ 151.65 | USD |
Period:
Draw Mode:
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 59.34B | 391.20M | 290.09M | $ 17.74B | $ 11.14B | 28.29 | 5.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -979.65k | 5.70% |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 174.435 | 180.13 | 150.6628 | 168.43 | 4,319,062 | -22.76 | -13.04% |
| 1 Month | 165.36 | 197.44 | 150.6628 | 173.17 | 4,504,176 | -13.68 | -8.27% |
| 3 Months | 130.85 | 197.44 | 115.61 | 154.65 | 5,134,016 | 20.83 | 15.92% |
| 6 Months | 147.55 | 197.44 | 115.61 | 152.92 | 6,172,089 | 4.13 | 2.8% |
| 1 Year | 406.38 | 464.85 | 115.61 | 254.43 | 9,072,706 | -254.70 | -62.68% |
| 3 Years | 13.25 | 497.17 | 13.02 | 152.79 | 12,121,321 | 138.43 | 1,044.75% |
| 5 Years | 22.00 | 497.17 | 11.54 | 149.70 | 10,135,704 | 129.68 | 589.45% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |